title: Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens.
abstract: Tobacco use is a major public health problem, and although many smokers report that they want to quit, only a small percentage succeed. Side effects associated with nicotine withdrawal, including depression, anxiety, and restlessness, certainly contribute to the low success rate. The dorsal raphe nucleus (DRN) is a serotonergic center with many functions, including control of mood and emotional state. We investigated the effect of nicotine on DRN neurons that project to the nucleus accumbens (NAc), an area involved in reward-related behaviors. Using a retrograde labeling method, we found that 75% of DRN-NAc projection neurons are serotonergic. In coronal slices that include the DRN, whole cell recordings were conducted on neurons identified by fluorescent backlabeling from NAc or randomly selected within the nucleus. Nicotine increased action potential firing rates in a subset of DRN neurons. Voltage-clamp recording revealed nicotinic acetylcholine receptor (nAChR)-mediated inward currents that contribute to the nicotine-induced excitation. Nicotinic receptors also indirectly affect excitability by modulating synaptic inputs to these neurons. Nicotine enhanced excitatory glutamatergic inputs to a subset of DRN-NAc projection neurons, while inhibitory γ-aminobutyric acid (GABA)ergic inputs were modulated either positively or negatively in a subset of these neurons. The net effect of nAChR activation is enhancement of serotonergic output from DRN to the NAc, which may contribute to the effects of nicotine on mood and affect.
authors: Department of Anesthesia & Critical Care, University of Chicago, 5841 South Maryland Ave., MC 4028, Chicago, IL 60637, USA.
authors: Ben
authors: B
authors: Chang
authors: Claire A
authors: CA
authors: Daniele
authors: Keith
authors: K
authors: Gallagher
authors: Michelle
authors: M
authors: Madonia
authors: Robert D
authors: RD
authors: Mitchum
authors: Lindy
authors: L
authors: Barrett
authors: Paul
authors: P
authors: Vezina
authors: Daniel S
authors: DS
authors: McGehee
references: Int J Neuropsychopharmacol. 2003 Mar;6(1):1-11
references: 12899731
references: Synapse. 2003 Sep 1;49(3):195-205
references: 12774304
references: Pharmacol Biochem Behav. 2002 Apr;71(4):757-71
references: 11888567
references: Eur Neuropsychopharmacol. 2001 Oct;11(5):359-66
references: 11597822
references: Ann N Y Acad Sci. 2000;909:170-85
references: 10911930
references: Brain Res. 1996 Oct 14;736(1-2):61-7
references: 8930309
references: Neuropharmacology. 2000;39(1):123-32
references: 10665825
references: Psychopharmacology (Berl). 2011 Feb;213(2-3):547-53
references: 20480149
references: J Pharmacol Exp Ther. 2001 Apr;297(1):357-63
references: 11259563
references: JAMA. 1990 Sep 26;264(12):1541-5
references: 2395193
references: J Neurosci. 1998 Mar 1;18(5):1904-12
references: 9465015
references: J Pharmacol Exp Ther. 2001 Apr;297(1):316-25
references: 11259559
references: Psychopharmacology (Berl). 2001 Apr;155(1):78-85
references: 11374339
references: Neuropsychopharmacology. 2001 Jul;25(1):55-71
references: 11377919
references: Brain Res Brain Res Protoc. 2004 Aug;13(3):183-8
references: 15296856
references: Addict Behav. 2003 Apr;28(3):461-70
references: 12628619
references: Brain Res. 2000 Jul 14;871(1):66-74
references: 10882784
references: J Neurophysiol. 2009 Nov;102(5):3026-37
references: 19710375
references: Neuron. 2000 Aug;27(2):349-57
references: 10985354
references: J Pharmacol Exp Ther. 2005 Apr;313(1):389-94
references: 15608080
references: Pharmacol Biochem Behav. 2001 Dec;70(4):531-49
references: 11796152
references: Brain Res. 2002 May 31;938(1-2):45-54
references: 12031534
references: Am J Addict. 2004 Oct-Dec;13(5):438-46
references: 15764422
references: Neuron. 2002 Mar 14;33(6):905-19
references: 11906697
references: J Neurosci. 2009 Jan 28;29(4):987-97
references: 19176807
references: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
references: 2899326
references: Drug Alcohol Depend. 1993 Jun;33(1):23-9
references: 8370337
references: Br J Pharmacol. 2010 Feb 1;159(3):554-65
references: 20105181
references: Naunyn Schmiedebergs Arch Pharmacol. 2000 Jul;362(1):41-5
references: 10935531
references: Ann N Y Acad Sci. 1990;600:9-34; discussion 34-5
references: 2252340
references: Brain Res. 2001 Mar 9;894(1):95-100
references: 11245819
references: Eur J Pharmacol. 2002 Sep 27;452(1):77-82
references: 12323387
references: Synapse. 2008 Aug;62(8):601-15
references: 18512214
references: J Pharmacol Exp Ther. 1993 Apr;265(1):373-7
references: 8474019
references: Brain Res. 2008 Sep 4;1228:89-96
references: 18619948
references: Pharmacol Biochem Behav. 2002 Apr;71(4):795-805
references: 11888570
references: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000031
references: 17253443
references: Psychopharmacology (Berl). 2011 Feb;213(2-3):337-54
references: 20577718
references: Curr Opin Neurobiol. 1996 Jun;6(3):342-9
references: 8794090
references: Neurosci Lett. 1989 Apr 10;98(3):276-9
references: 2657504